GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
PL323314A1
(en)
|
1995-05-09 |
1998-03-16 |
Colorcon Ltd |
Electrostatic application of coatings
|
US7008668B2
(en)
|
1995-05-09 |
2006-03-07 |
Phoqus Pharmaceuticals Limited |
Powder coating composition for electrostatic coating of pharmaceutical substrates
|
US5750147A
(en)
*
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
CA2240161C
(en)
|
1996-05-20 |
2005-05-24 |
Janssen Pharmaceutica N.V. |
Antifungal compositions with improved bioavailability
|
US5846971A
(en)
*
|
1996-06-28 |
1998-12-08 |
Schering Corporation |
Oral antifungal composition
|
TR199802718T2
(xx)
*
|
1996-06-28 |
1999-03-22 |
Schering Corporation |
Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im.
|
GB9623634D0
(en)
|
1996-11-13 |
1997-01-08 |
Bpsi Holdings Inc |
Method and apparatus for the coating of substrates for pharmaceutical use
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
ATE241969T1
(de)
*
|
1997-03-26 |
2003-06-15 |
Janssen Pharmaceutica Nv |
Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
|
KR19990001564A
(ko)
*
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
CA2317106C
(en)
*
|
1997-12-31 |
2004-11-23 |
Choongwae Pharma Corporation |
Method and composition of an oral preparation of itraconazole
|
KR100514330B1
(ko)
*
|
1997-12-31 |
2006-02-17 |
주식회사 중외제약 |
난용성 약물을 함유하는 코팅정
|
DE19808634A1
(de)
*
|
1998-02-24 |
1999-08-26 |
Schering Ag |
Mantel für eine pharmazeutische Zusammensetzung
|
UA65607C2
(uk)
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
JP2002520351A
(ja)
*
|
1998-07-17 |
2002-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗菌・カビ剤及びポリマーを被覆したコアを有するペレット
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
DE60023465T2
(de)
|
1999-03-24 |
2006-07-20 |
R.P. Scherer Technologies, Inc., Las Vegas |
Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
KR100694667B1
(ko)
*
|
1999-12-08 |
2007-03-14 |
동아제약주식회사 |
생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
|
JP5159012B2
(ja)
*
|
1999-12-23 |
2013-03-06 |
メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド |
不良溶解性の薬物に対する改良された医薬組成物
|
CN1310999A
(zh)
*
|
2000-02-29 |
2001-09-05 |
布里斯托尔-迈尔斯斯奎布公司 |
低剂量艾替开韦制剂及其应用
|
US6551608B2
(en)
*
|
2000-03-06 |
2003-04-22 |
Porex Technologies Corporation |
Porous plastic media with antiviral or antimicrobial properties and processes for making the same
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US6673373B2
(en)
|
2001-02-01 |
2004-01-06 |
Carlsbad Technology Inc. |
Antifungal formulation and the methods for manufacturing and using the same
|
US6663897B2
(en)
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
CN101230067B
(zh)
|
2001-02-14 |
2011-06-15 |
泰博特克药品有限公司 |
广谱的2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂
|
AU2002257774B2
(en)
|
2001-04-09 |
2007-08-30 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
|
EP1387842B1
(en)
|
2001-05-11 |
2009-04-22 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
KR100438485B1
(ko)
*
|
2001-08-13 |
2004-07-09 |
한국디디에스제약 주식회사 |
아졸류 항진균제의 약제학적 조성물
|
US8071133B2
(en)
|
2001-08-20 |
2011-12-06 |
Stiefel Laboratories, Inc. |
Oral dosage forms of water insoluble drugs and methods of making the same
|
US8309118B2
(en)
*
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
CA2363376A1
(en)
*
|
2001-11-16 |
2003-05-16 |
Bernard Charles Sherman |
Solid pharmaceutical compositions for oral administration comprising itraconazole
|
EP1463502B1
(en)
|
2001-12-21 |
2011-07-13 |
Tibotec Pharmaceuticals |
Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US7446107B2
(en)
*
|
2002-02-15 |
2008-11-04 |
Transform Pharmaceuticals, Inc. |
Crystalline forms of conazoles and methods of making and using the same
|
WO2003101392A2
(en)
*
|
2002-05-31 |
2003-12-11 |
Transform Pharmaceuticals, Inc. |
Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
EP1494998A2
(en)
|
2002-03-01 |
2005-01-12 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
KR20100130234A
(ko)
|
2002-05-17 |
2010-12-10 |
티보텍 파마슈티컬즈 |
광범위 스펙트럼의 치환된 벤즈이속사졸 설폰아미드 hiv 프로테아제 저해제
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
IL165383A0
(en)
*
|
2002-06-21 |
2006-01-15 |
Transform Pharmaceuticals Inc |
Pharmaceutical compositions with improved dissolution
|
AU2003256089A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Nanohybrid Co., Ltd. |
Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
JP4681296B2
(ja)
|
2002-08-14 |
2011-05-11 |
テイボテク・フアーマシユーチカルズ・リミテツド |
スペクトルの広い置換オキシインドールスルホンアミドhivプロテアーゼ阻害剤
|
US20040086567A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Pawan Seth |
Bioequivalent composition of itraconazole and a hydrophilic polymer
|
BR0215954A
(pt)
|
2002-11-26 |
2005-09-13 |
Uc Tech |
Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
DE60312635T3
(de)
*
|
2003-01-14 |
2013-05-08 |
Cimex Pharma Ag |
Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
|
ATE357235T1
(de)
*
|
2003-01-14 |
2007-04-15 |
Cimex Pharma Ag |
Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer
|
FR2852607B1
(fr)
*
|
2003-03-20 |
2006-07-14 |
|
Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
|
US8268885B2
(en)
|
2003-09-11 |
2012-09-18 |
Janssen R&D Ireland |
Entry inhibitors of the HIV virus
|
US20050074494A1
(en)
*
|
2003-10-06 |
2005-04-07 |
Xiu-Xiu Cheng |
Itraconazole immediate release formulation
|
US20050118265A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Anandi Krishnan |
Antifungal oral dosage forms and the methods for preparation
|
US9247765B2
(en)
|
2004-01-14 |
2016-02-02 |
Omniactive Health Technologies Limited |
Stable beadlets of lipophilic nutrients
|
US20050249799A1
(en)
*
|
2004-03-03 |
2005-11-10 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
CN1997363B
(zh)
|
2004-05-07 |
2012-03-28 |
塞阔伊亚药品公司 |
抗耐药性反转录病毒蛋白酶抑制剂
|
EA012330B1
(ru)
|
2004-05-17 |
2009-08-28 |
Тиботек Фармасьютикалз Лтд. |
1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
|
BRPI0511267A
(pt)
|
2004-05-17 |
2007-11-27 |
Tibotec Pharm Ltd |
1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
|
BRPI0511173A
(pt)
|
2004-05-17 |
2007-12-04 |
Tibotec Pharm Ltd |
1-fenil-1,5-diidro-pirido-(3,2b)indol-2-onas substituìdas nas posições 6,7,8,9, de utilidade como agentes farmacêuticos antiinfecciosos
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US20060045822A1
(en)
|
2004-09-01 |
2006-03-02 |
Board Of Regents, The University Of Texas System |
Plasma polymerization for encapsulating particles
|
US20100297248A1
(en)
*
|
2004-09-01 |
2010-11-25 |
Board Of Regents, The University Of Texas System |
Encapsulated particles for amorphous stability enhancement
|
FR2883179B1
(fr)
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
TW200710091A
(en)
|
2005-04-11 |
2007-03-16 |
Tibotec Pharm Ltd |
(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
|
US20090118721A1
(en)
*
|
2005-07-21 |
2009-05-07 |
Eric Bornstein |
Near Infrared Microbial Elimination Laser System (NIMELS)
|
US20070148240A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Fang-Yu Lee |
Oral formulation containing itraconazole and methods for manufacturing and using the same
|
JP2009534311A
(ja)
|
2006-04-03 |
2009-09-24 |
テイボテク・フアーマシユーチカルズ・リミテツド |
HIV阻害性3,4−ジヒドロ−イミダゾ[4,5−b]ピリジン−5−オン
|
CN101091725A
(zh)
*
|
2006-06-23 |
2007-12-26 |
天津天士力制药股份有限公司 |
一种中药颗粒及其制备方法
|
US20100151035A1
(en)
*
|
2007-03-13 |
2010-06-17 |
Sandoz Ag |
Pharmaceutical compositions of poorly soluble drugs
|
CN101283984B
(zh)
*
|
2007-04-12 |
2010-05-26 |
永胜药品工业股份有限公司 |
高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
|
JP2008280254A
(ja)
*
|
2007-05-08 |
2008-11-20 |
Everest Pharm Industrial Co Ltd |
生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
|
JP5745855B2
(ja)
|
2007-11-28 |
2015-07-08 |
セコイア、ファーマシューティカルズ、インコーポレイテッドSequoia Pharmaceuticals,Inc. |
シトクロムp450 2d6を阻害するための組成物および方法
|
WO2009105776A1
(en)
|
2008-02-21 |
2009-08-27 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome p450
|
WO2009114834A2
(en)
|
2008-03-13 |
2009-09-17 |
Board Of Regents, The University Of Texas System |
Covalently functionalized particles for synthesis of new composite materials
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
GB2479213B
(en)
|
2010-04-01 |
2013-07-10 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
WO2011146078A1
(en)
*
|
2010-05-21 |
2011-11-24 |
Board Of Regents, The University Of Texas System |
Encapsulated particles for enteric release
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
CN103402543B
(zh)
*
|
2010-12-16 |
2015-09-16 |
德克萨斯州立大学董事会 |
用于胃肠外施用的吡咯药物制剂及其制备方法和治疗对吡咯化合物敏感的疾病的使用方法
|
CA2835277A1
(en)
|
2011-05-10 |
2012-11-15 |
Theravida, Inc. |
Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
|
WO2013192566A1
(en)
|
2012-06-21 |
2013-12-27 |
Mayne Pharma International Pty. Ltd. |
Itraconazole compositions and dosage forms, and methods of using the same
|
CN103948911B
(zh)
*
|
2014-04-23 |
2016-04-20 |
深圳市健元医药科技有限公司 |
一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
WO2017127073A1
(en)
|
2016-01-20 |
2017-07-27 |
Theravida, Inc. |
Methods and compositions for treating hyperhidrosis
|
EP3544614A4
(en)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
ORAL TESTOSTERONE UNDECANOATE THERAPY
|